{"ticker": {"uuid": "037673e2-d3bb-4b4f-ae36-8298ab94331b", "symbol": "MNOV", "name": "MediciNova Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN\u2011166 (ibudilast) in ALS patients", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/medicinova-announces-patient-enrollment-milestone-120000512.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ALS patients ineligible for trials join MediciNova's 200-person study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNd09qT1ZqZHE2c2t0Q3pkbERxRnJHTjBaNU1lMnZiV2s3dkpJZDZzd1ZMZ2hyYjB0TG44ZnJyckR5UktSTU1pNnhkbU5mU3BUaXlhYUphcnRoeTZrOHVWMHRnLUtBT3Rybm9Jd1RzZmdHcW9oM2h0bXk0WG1QY2JPRUlsWXFQWGdiMnpjQkFXb3dCS2lfeTFmdFFYc1phdm1wblM0X1pmaU5lVjVUcHZYXy03aGoyV2ls?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediciNova Inc outlines its biotech pipeline as investors watch MN-166 progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZ2Q5b1dUZ0sxUFE3RjhvZWJnZHZJVEJRVHc3eERiRXhFbkpVejgwMmpaaU93ejE4S1lWOHAtVldMSDJXZW80QVV0a1kzNGFnV3RPbXJNY09nLVkwcVp2THg3YjNiLVFyTm9JRVNHRENTOEJQXzlCSTlUSGZDVUlOUWVVTVI4LWl1SHR4aElDQVVQM3hSenVMcVVRTjVwOWpldkFRN3hpNGsySVhVa2YxUkprRnA1SVdWckpOLVNWYjc0RGxPWHZoOQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-07T12:39:49+00:00", "published_display": "07 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Holds Steady Near Support After Modest Advance - Factor Crowding", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcS16TzVrd2gtXzROSHpJaGdfczlJRHM4UndpWjdGelRaXzRJNEFwSXBWZ2tKSWdDOUc1cVdiSm5jdWF1eHozX0ZKZHZwRmU4M3l3RWxrSDllNXR3NjJQbkd0Y1ZLZDFkLUhBeUxsSW5YVTdkQkp5OHRXanlmRG1Tb3VaZmc1Vm9GOG00VEZNZDF6VHFuM1p0WlJrTW1GS0lvaWZKRU1teUpyZmFqMThR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-02T14:31:37+00:00", "published_display": "02 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Surges 7.6% as Biotech Stock Tests Resistance at $1.49 - Buffered ETF", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNUUZabUZNbGNmenNZdlh4R0dKSDlzRnR3MmhQRzZvQVkyTENIblRSYmJ4eGtNak9tbXllYlRaTHZSQ2pHdnVkUk9LZlBmZ0prNkdLNjZqTTg3aGdadjR3dEo1U0ZDNEtUeHR1T2pxQ080SEQ2UXlJVkZKUXduOWlZSnVNczNyeUN2VFZWdEFNbUFYYm42T0Q2bVpWTlpvb051amc5czA3YkxSdzM1aWJyZ0pR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-02T02:33:43+00:00", "published_display": "02 Jul 2026 02:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova CEO Provides Shareholder Update", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/medicinova-ceo-provides-shareholder-120000335.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T12:00:00+00:00", "published_display": "30 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova awaits Q3 data as ALS study hits 100 patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMFA3Tl95Wmw1VW1JdjFfY0lzeDJRbU5tdFhmS3dzUWM3RndidjlNQ2lpVE5jYi1GQW5nUFYwYVRhNDdiRVFQVm5ZdWhUX280SkxNeXFmWnVJU2ROZVNXdWpEdTRFdVBiR00yQWhtbmRQVEg2SXJyeU1zbXRncXdsUUMzd1FyVjZ5RjFueEU3TERVYW41bEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 MediciNova Inc For: 25 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbTB5SEtub0pXQm5mSlA0aV9aM2dmenRuZHZpWGFmbFpmc0VsTXIwZG9Ic1gyVlp0QlJCcE9Obngzd2UyUm9pd0lfYUtMbjlXc0E1MndDWUVhOE5uNWZlRWdxdzVXeTEwWXMzN3A5a0dwenBiQWNUQmk4MXVyc2M4ajg0T3lGQ00wN3VnVHo4Z3puSjE5cGxIdXl3?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director awarded 44,500 stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPNTlYVVNCRURVQ0VtNVYzWkl4UU1Zb1huQ04zc0NRT2UwVi1BUlJiZW1mblFtTkQtd19uVC1iQUstUkMwemszWTc5RzVQbmNMdFd0bmFEcHdnVzBkcjVTY1RFWm01TkFENWtHVFNuVm0tcHhhdm1raW1IYUJLa04yZEVqcGVMa3N4NExHYm44OGNNTHFtTkoxdmVPazBDSHVxRDhtNGVUbVlyRmVZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director receives grant of 44,500 stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOblg0YjBXaFdiNnloSDI5cXQ1TktKUE9hcXlVeFJtMWNvaFJLbWlONjVobTdPZDdNT2ZhdEpjakVvTUN3allqU3VKN2g0ZEZuMW9NM2YzN3BDVVNweERxQ3hKOFY2SzJCQlBSUXVwX1JUUlU2aXRhbk9LcUtDRVVSX2xEMHdOQU5ScXVicndUWDRyMnNNS2FFSlBCN005Q2lLdmFrWEh1dlR5V18x?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director Nicole Lemerond receives 44,500 stock options grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQUS0waXNWMGpQc0ZrWkZyNC1FVVllRW8tX3l2d1QyWFpYTm5xd0FpY3o4U1drT1dfSXBBMzk4SVFGZU94UjZrWlVsRm5GclVadE9rTmY4VjgwbXg4dnlZeEZhRVBwdFl6Y0thMG5idm9kMzRQM0RJb2JRenN6MHFZMzlYUHFVV2R6SnRwWG84RXE1Qktyb2JZcTZDaXJLQnNjTjNYM096S3RHdlM0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Holds Near Support Amid Modest Decline - Range Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNb3A3YTVrRDFYSmdEd0pUU1RxYmJvMEpSUUtBMHRIUTBMZ1BETlFGek5yRm5YZmc4cU9lemZPOUc5OFc5LUFnRnlMeXpxNzdITmdfdms5UjRQcy05QndDTFI5dnBnNXBIM0Y3eWVVLWpVMkpzWUxYcXRVeGoxeUFVX24xX3JSN0o1Zy1UTElBajlSbWRqODNEQkh2eFdFWEt5ZFV5YQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Granted US Patent Notice of Allowance for Ibudilast Combination to Treat Brain Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-granted-us-patent-notice-123414242.html", "source_name": "MT Newswires", "published_at": "2026-06-08T12:34:14+00:00", "published_display": "08 Jun 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-receives-notice-allowance-patent-120000621.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T12:00:00+00:00", "published_display": "08 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Inc stock (US58468P2038): Nasdaq biotech share edges higher while valuation metrics stay subdued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPQ1pMMWN6U0RrRDN6S3p5bExaYmlXaTlCbUZpTGdUdnBnUloxYWxqY3VKakpvY09JSEU0QTZibnpBdmVOelFVT3d4RjY3UUlQZ2ZtT0hNVUpNTzg3QXQ4dms3c3VzX2FPUUJRLWswRGFGdDJfMzN4cmlYS0tJb21uMEFYXzZaaTU1YWwyZjJJUW5jNXR2MmtVWUJPeDg1QXlHSFRTdlVJM1R4M2xZd1k3NmxheFNhbDZUOFZockI5RjVnMkhC?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Edges Higher on Modest Volume, Faces Key Resistance at $1.41 - Shakeout Pattern", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQamZKTDdrR1pZVlRBT25oWWY5dVE2NGNLcE1sb2VVS1VURndEcUhpNVpLUzkwVUFHSmQ4YU5DNkxud2dmYnlTYkVMVzZXZ0RfLV9heUt6ZzNsUzlKdS03YUN3VExLYzQwMldIZENFQzYtMjUxWFJoTHhOZVV1Rno4eGlMYm5MYlhwazlZX3poVFlYU3BrYjVKLXdUZWIxV2JMZUxjUXZGNVlxRWFDYU42dmNJUWVqRDlUcmNTZGV5OUp2R3c?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - Hagopian Line", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPN2NwX0NmOE03ZmFZS0JpclNCR3RwM21ZVmltelN5UU81OVlXWTJEV1VlSjVxN2NPRVlTcG5ScThQX0JLZFhQay1pMU1KVlBrUWNMeHJQdWxsTHdyV0pJY2RYYy1VWVhmTFJfQTdFYWp3eEh6RG9ZajVsTVBKZUw0TWI3VGZwdW0ybE8wX3g4LURLQXJXLXE3ZXRlWnR6VjRjekV3ZGYteHBOWGpzMlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Slips to $1.33 as Shares Retreat 2.92% - Stop Hunt", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQeFE2SGIxZTFnZElLcEhHdzA0MWlSX0dfdmYweU4zNXNGUXVQaVRWQ0JCemU2eWh3MHpWX180ZHdtVzkyWmlXbTZBZ3lKWGswX05vX2tlNGM0Tm1RQjU0RnJzRzhVeW1POXB1NXhXWUlwN3BMcjhWSUp3dTI1LXFwWllyMTFQM2hYclZmUXVudk44NFA3VXJ3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - MA Crossover", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMkVDdTYtODc3NVd6SVFfWWxsLTlwVHV3QjNKSEFlR3M2ak1DZDI0bjdKODZOX2c3V29wUE5IN195dVZlRlNFNmp0T1Nnb0NNTHRRSTZXUGt0OGV4SDY4SEw1WTNyWmQwNUdHdTNLSUlUamFFb3poLVRNOGpQT0lvaVNFTWs2TkxLMEVUdVh4Y25nQXgzOURFLWpiUEdBXzlrbHhSSg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - Double EMA", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbGljLWVFZnU2VFBBZERnSko1RlJMS1VTcGpQZkU1SVFzT2Q5Qk9pWXpnSTBWU2VaeGFhZEFvM19saExBYktzVFRSVDFfbW9zZ05vb3VlU09kQng1azU2Ul9za3pXeTRmNVFzMmxrZWtMMWxJZlg1amRfS1BzZG5oLVp5dTJ4N0hNOUNnXzdRRG1iTnJWS0VaNEJPNEdUcVk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-announces-completion-last-patient-230000395.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T23:00:00+00:00", "published_display": "26 May 2026 23:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Announces Completion of Last Patient Last Visit", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPcnJpdkUxakx3ZXl1U3BXMDM2ZXlGZ01yc3BIZWRBOHNJRUxLYS1HQm0zdnNRZXJ1V3FvSzQtOENORnJabUpaUFp5dGZLa2JqWE1UaU9nSF9Kd2ItaXB5cXIwYlFndzZOTF9hWlljT09OcXp0QnUwOHlaYWlMZVBEY2hYNjlaX3RIRmxmXzBRemxGS25nbXRCWWJHNkhuajhlNndDRmhuajdzWkZuMVYxY2ZTUkdLX1NyTURBZ0h2N0tUb0pveG10bVJqYWpVY216dmZyZHpXcDNvWUFLcmFBSEd2bmc4bnNQd1JBTU5fU1RxZThlNGtrOXNDS0JBMTMwTU9kQmh4TzhVRDA5T2ZkQTNwOENJUUZPYXZUUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNd0o3aEJ1X0w5RFAwZHViN290VkhHSXhzRl9WZ0NvOFlMZ3Bod212Rl81WU9MdE40TDNJYmFKUzhvVE1tdG55dEtCQmVIYkduZWhQY0RBa0VBaDYxbnY2YXRZMGVTblpmblNUbXdhcTY5MDdhZHc0R1VhM181TzJwQmhFYkFEQUxVaG1jSmdqWUxuWmZ5RXJZRGJ0enFzdlkyaXc?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediciNova: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-q1-earnings-snapshot-224459836.html", "source_name": "Associated Press", "published_at": "2026-05-14T22:44:59+00:00", "published_display": "14 May 2026 22:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "New Peer\u2011Reviewed Study Reveals Actionable Immune\u2013Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/peer-reviewed-study-reveals-actionable-230000973.html", "source_name": "GlobeNewswire", "published_at": "2026-04-27T23:00:00+00:00", "published_display": "27 Apr 2026 23:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MediciNova Announces 100 Patients Enrolled in SEANOBI Study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxOVW5BTjJ3eXFPSUJlVmhRTmU0UXl4YXAyRFlEMkxKaXpkYjRqQlRMNklYc2pCb3ZJZTU0MnZYUEMxRzN3Z21vV1UxakZnVmRrSDV0TWYxckh2Z2lDRi1OV29TU3R0bzNJZFlWejY3Slg3MXo4Nk1yMDFYUDJHb29hRklWX1VlMjVPYzZIQ0xxY3dtaEhyTTNQV3FLbENkR01fTjNBREwxemlMNEtNX3daNEZXV1o5dDluTlJzQzZYU2thUzAtRnIyQ2ZDU3NlZnlCNlEwVHAzalAxYVlxZnR4c0NqQl9MQ3R5eVV0WGNSdENhNGFBemJBTHg1X0xQaEZpRHdfV3pjeG1NMzhqTVdVLU9wMTdZa1ZVbmxrWW1UNjl4S194YUh1V3poVQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1DbTFFZGZRMDJDVHRQZmR3ODllMDJxOFRrX05YdXVMa0Y5MjFGdGdXcFNHbHpIQWV2RmswNzRPVTIwdVFvYnJVVmpnTjYzbU1mdm1n?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:55:31+00:00", "published_display": "24 Apr 2025 23:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2025-04-15T07:00:00+00:00", "published_display": "15 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5lS3hDekNKQTJiV0FNc18yYkpyZnhQWlFqWm5YZVJ3REFYM19LZFE5Ump1RHBSZVdvV2xKM0kySXE5VW9EcDhtSG0ycXJ4UQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-12T03:55:05+00:00", "published_display": "12 Sep 2020 03:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RMN.F - MediciNova, Inc. Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBYMnpGSHNUNUF5ZlFIRUk0TktTRHNmaHA0dWpPV0o3OVNUS01ETUhxbjY4bk9FSUJFYXljdUtuZUhEZG4zS21iZA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-09-03T18:55:45+00:00", "published_display": "03 Sep 2020 18:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN\u2011166 (ibudilast) in ALS patients", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/medicinova-announces-patient-enrollment-milestone-120000512.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ALS patients ineligible for trials join MediciNova's 200-person study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNd09qT1ZqZHE2c2t0Q3pkbERxRnJHTjBaNU1lMnZiV2s3dkpJZDZzd1ZMZ2hyYjB0TG44ZnJyckR5UktSTU1pNnhkbU5mU3BUaXlhYUphcnRoeTZrOHVWMHRnLUtBT3Rybm9Jd1RzZmdHcW9oM2h0bXk0WG1QY2JPRUlsWXFQWGdiMnpjQkFXb3dCS2lfeTFmdFFYc1phdm1wblM0X1pmaU5lVjVUcHZYXy03aGoyV2ls?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Inc outlines its biotech pipeline as investors watch MN-166 progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZ2Q5b1dUZ0sxUFE3RjhvZWJnZHZJVEJRVHc3eERiRXhFbkpVejgwMmpaaU93ejE4S1lWOHAtVldMSDJXZW80QVV0a1kzNGFnV3RPbXJNY09nLVkwcVp2THg3YjNiLVFyTm9JRVNHRENTOEJQXzlCSTlUSGZDVUlOUWVVTVI4LWl1SHR4aElDQVVQM3hSenVMcVVRTjVwOWpldkFRN3hpNGsySVhVa2YxUkprRnA1SVdWckpOLVNWYjc0RGxPWHZoOQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-07T12:39:49+00:00", "published_display": "07 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Holds Steady Near Support After Modest Advance - Factor Crowding", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcS16TzVrd2gtXzROSHpJaGdfczlJRHM4UndpWjdGelRaXzRJNEFwSXBWZ2tKSWdDOUc1cVdiSm5jdWF1eHozX0ZKZHZwRmU4M3l3RWxrSDllNXR3NjJQbkd0Y1ZLZDFkLUhBeUxsSW5YVTdkQkp5OHRXanlmRG1Tb3VaZmc1Vm9GOG00VEZNZDF6VHFuM1p0WlJrTW1GS0lvaWZKRU1teUpyZmFqMThR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-02T14:31:37+00:00", "published_display": "02 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Surges 7.6% as Biotech Stock Tests Resistance at $1.49 - Buffered ETF", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNUUZabUZNbGNmenNZdlh4R0dKSDlzRnR3MmhQRzZvQVkyTENIblRSYmJ4eGtNak9tbXllYlRaTHZSQ2pHdnVkUk9LZlBmZ0prNkdLNjZqTTg3aGdadjR3dEo1U0ZDNEtUeHR1T2pxQ080SEQ2UXlJVkZKUXduOWlZSnVNczNyeUN2VFZWdEFNbUFYYm42T0Q2bVpWTlpvb051amc5czA3YkxSdzM1aWJyZ0pR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-02T02:33:43+00:00", "published_display": "02 Jul 2026 02:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova CEO Provides Shareholder Update", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/medicinova-ceo-provides-shareholder-120000335.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T12:00:00+00:00", "published_display": "30 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova awaits Q3 data as ALS study hits 100 patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMFA3Tl95Wmw1VW1JdjFfY0lzeDJRbU5tdFhmS3dzUWM3RndidjlNQ2lpVE5jYi1GQW5nUFYwYVRhNDdiRVFQVm5ZdWhUX280SkxNeXFmWnVJU2ROZVNXdWpEdTRFdVBiR00yQWhtbmRQVEg2SXJyeU1zbXRncXdsUUMzd1FyVjZ5RjFueEU3TERVYW41bEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 MediciNova Inc For: 25 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbTB5SEtub0pXQm5mSlA0aV9aM2dmenRuZHZpWGFmbFpmc0VsTXIwZG9Ic1gyVlp0QlJCcE9Obngzd2UyUm9pd0lfYUtMbjlXc0E1MndDWUVhOE5uNWZlRWdxdzVXeTEwWXMzN3A5a0dwenBiQWNUQmk4MXVyc2M4ajg0T3lGQ00wN3VnVHo4Z3puSjE5cGxIdXl3?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director awarded 44,500 stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPNTlYVVNCRURVQ0VtNVYzWkl4UU1Zb1huQ04zc0NRT2UwVi1BUlJiZW1mblFtTkQtd19uVC1iQUstUkMwemszWTc5RzVQbmNMdFd0bmFEcHdnVzBkcjVTY1RFWm01TkFENWtHVFNuVm0tcHhhdm1raW1IYUJLa04yZEVqcGVMa3N4NExHYm44OGNNTHFtTkoxdmVPazBDSHVxRDhtNGVUbVlyRmVZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director receives grant of 44,500 stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOblg0YjBXaFdiNnloSDI5cXQ1TktKUE9hcXlVeFJtMWNvaFJLbWlONjVobTdPZDdNT2ZhdEpjakVvTUN3allqU3VKN2g0ZEZuMW9NM2YzN3BDVVNweERxQ3hKOFY2SzJCQlBSUXVwX1JUUlU2aXRhbk9LcUtDRVVSX2xEMHdOQU5ScXVicndUWDRyMnNNS2FFSlBCN005Q2lLdmFrWEh1dlR5V18x?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova (MNOV) director Nicole Lemerond receives 44,500 stock options grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQUS0waXNWMGpQc0ZrWkZyNC1FVVllRW8tX3l2d1QyWFpYTm5xd0FpY3o4U1drT1dfSXBBMzk4SVFGZU94UjZrWlVsRm5GclVadE9rTmY4VjgwbXg4dnlZeEZhRVBwdFl6Y0thMG5idm9kMzRQM0RJb2JRenN6MHFZMzlYUHFVV2R6SnRwWG84RXE1Qktyb2JZcTZDaXJLQnNjTjNYM096S3RHdlM0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Holds Near Support Amid Modest Decline - Range Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNb3A3YTVrRDFYSmdEd0pUU1RxYmJvMEpSUUtBMHRIUTBMZ1BETlFGek5yRm5YZmc4cU9lemZPOUc5OFc5LUFnRnlMeXpxNzdITmdfdms5UjRQcy05QndDTFI5dnBnNXBIM0Y3eWVVLWpVMkpzWUxYcXRVeGoxeUFVX24xX3JSN0o1Zy1UTElBajlSbWRqODNEQkh2eFdFWEt5ZFV5YQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Granted US Patent Notice of Allowance for Ibudilast Combination to Treat Brain Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-granted-us-patent-notice-123414242.html", "source_name": "MT Newswires", "published_at": "2026-06-08T12:34:14+00:00", "published_display": "08 Jun 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-receives-notice-allowance-patent-120000621.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T12:00:00+00:00", "published_display": "08 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Inc stock (US58468P2038): Nasdaq biotech share edges higher while valuation metrics stay subdued", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPQ1pMMWN6U0RrRDN6S3p5bExaYmlXaTlCbUZpTGdUdnBnUloxYWxqY3VKakpvY09JSEU0QTZibnpBdmVOelFVT3d4RjY3UUlQZ2ZtT0hNVUpNTzg3QXQ4dms3c3VzX2FPUUJRLWswRGFGdDJfMzN4cmlYS0tJb21uMEFYXzZaaTU1YWwyZjJJUW5jNXR2MmtVWUJPeDg1QXlHSFRTdlVJM1R4M2xZd1k3NmxheFNhbDZUOFZockI5RjVnMkhC?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Edges Higher on Modest Volume, Faces Key Resistance at $1.41 - Shakeout Pattern", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQamZKTDdrR1pZVlRBT25oWWY5dVE2NGNLcE1sb2VVS1VURndEcUhpNVpLUzkwVUFHSmQ4YU5DNkxud2dmYnlTYkVMVzZXZ0RfLV9heUt6ZzNsUzlKdS03YUN3VExLYzQwMldIZENFQzYtMjUxWFJoTHhOZVV1Rno4eGlMYm5MYlhwazlZX3poVFlYU3BrYjVKLXdUZWIxV2JMZUxjUXZGNVlxRWFDYU42dmNJUWVqRDlUcmNTZGV5OUp2R3c?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - Hagopian Line", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPN2NwX0NmOE03ZmFZS0JpclNCR3RwM21ZVmltelN5UU81OVlXWTJEV1VlSjVxN2NPRVlTcG5ScThQX0JLZFhQay1pMU1KVlBrUWNMeHJQdWxsTHdyV0pJY2RYYy1VWVhmTFJfQTdFYWp3eEh6RG9ZajVsTVBKZUw0TWI3VGZwdW0ybE8wX3g4LURLQXJXLXE3ZXRlWnR6VjRjekV3ZGYteHBOWGpzMlE?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova Inc (MNOV) Slips to $1.33 as Shares Retreat 2.92% - Stop Hunt", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQeFE2SGIxZTFnZElLcEhHdzA0MWlSX0dfdmYweU4zNXNGUXVQaVRWQ0JCemU2eWh3MHpWX180ZHdtVzkyWmlXbTZBZ3lKWGswX05vX2tlNGM0Tm1RQjU0RnJzRzhVeW1POXB1NXhXWUlwN3BMcjhWSUp3dTI1LXFwWllyMTFQM2hYclZmUXVudk44NFA3VXJ3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - MA Crossover", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMkVDdTYtODc3NVd6SVFfWWxsLTlwVHV3QjNKSEFlR3M2ak1DZDI0bjdKODZOX2c3V29wUE5IN195dVZlRlNFNmp0T1Nnb0NNTHRRSTZXUGt0OGV4SDY4SEw1WTNyWmQwNUdHdTNLSUlUamFFb3poLVRNOGpQT0lvaVNFTWs2TkxLMEVUdVh4Y25nQXgzOURFLWpiUEdBXzlrbHhSSg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Slides 4% as Stock Tests Key Support Near $1.24 - Double EMA", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbGljLWVFZnU2VFBBZERnSko1RlJMS1VTcGpQZkU1SVFzT2Q5Qk9pWXpnSTBWU2VaeGFhZEFvM19saExBYktzVFRSVDFfbW9zZ05vb3VlU09kQng1azU2Ul9za3pXeTRmNVFzMmxrZWtMMWxJZlg1amRfS1BzZG5oLVp5dTJ4N0hNOUNnXzdRRG1iTnJWS0VaNEJPNEdUcVk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-announces-completion-last-patient-230000395.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T23:00:00+00:00", "published_display": "26 May 2026 23:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Announces Completion of Last Patient Last Visit", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPcnJpdkUxakx3ZXl1U3BXMDM2ZXlGZ01yc3BIZWRBOHNJRUxLYS1HQm0zdnNRZXJ1V3FvSzQtOENORnJabUpaUFp5dGZLa2JqWE1UaU9nSF9Kd2ItaXB5cXIwYlFndzZOTF9hWlljT09OcXp0QnUwOHlaYWlMZVBEY2hYNjlaX3RIRmxmXzBRemxGS25nbXRCWWJHNkhuajhlNndDRmhuajdzWkZuMVYxY2ZTUkdLX1NyTURBZ0h2N0tUb0pveG10bVJqYWpVY216dmZyZHpXcDNvWUFLcmFBSEd2bmc4bnNQd1JBTU5fU1RxZThlNGtrOXNDS0JBMTMwTU9kQmh4TzhVRDA5T2ZkQTNwOENJUUZPYXZUUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNd0o3aEJ1X0w5RFAwZHViN290VkhHSXhzRl9WZ0NvOFlMZ3Bod212Rl81WU9MdE40TDNJYmFKUzhvVE1tdG55dEtCQmVIYkduZWhQY0RBa0VBaDYxbnY2YXRZMGVTblpmblNUbXdhcTY5MDdhZHc0R1VhM181TzJwQmhFYkFEQUxVaG1jSmdqWUxuWmZ5RXJZRGJ0enFzdlkyaXc?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/medicinova-q1-earnings-snapshot-224459836.html", "source_name": "Associated Press", "published_at": "2026-05-14T22:44:59+00:00", "published_display": "14 May 2026 22:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Peer\u2011Reviewed Study Reveals Actionable Immune\u2013Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/peer-reviewed-study-reveals-actionable-230000973.html", "source_name": "GlobeNewswire", "published_at": "2026-04-27T23:00:00+00:00", "published_display": "27 Apr 2026 23:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova Announces 100 Patients Enrolled in SEANOBI Study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxOVW5BTjJ3eXFPSUJlVmhRTmU0UXl4YXAyRFlEMkxKaXpkYjRqQlRMNklYc2pCb3ZJZTU0MnZYUEMxRzN3Z21vV1UxakZnVmRrSDV0TWYxckh2Z2lDRi1OV29TU3R0bzNJZFlWejY3Slg3MXo4Nk1yMDFYUDJHb29hRklWX1VlMjVPYzZIQ0xxY3dtaEhyTTNQV3FLbENkR01fTjNBREwxemlMNEtNX3daNEZXV1o5dDluTlJzQzZYU2thUzAtRnIyQ2ZDU3NlZnlCNlEwVHAzalAxYVlxZnR4c0NqQl9MQ3R5eVV0WGNSdENhNGFBemJBTHg1X0xQaEZpRHdfV3pjeG1NMzhqTVdVLU9wMTdZa1ZVbmxrWW1UNjl4S194YUh1V3poVQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1DbTFFZGZRMDJDVHRQZmR3ODllMDJxOFRrX05YdXVMa0Y5MjFGdGdXcFNHbHpIQWV2RmswNzRPVTIwdVFvYnJVVmpnTjYzbU1mdm1n?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:55:31+00:00", "published_display": "24 Apr 2025 23:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2025-04-15T07:00:00+00:00", "published_display": "15 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medicinova (MNOV) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5lS3hDekNKQTJiV0FNc18yYkpyZnhQWlFqWm5YZVJ3REFYM19LZFE5Ump1RHBSZVdvV2xKM0kySXE5VW9EcDhtSG0ycXJ4UQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-12T03:55:05+00:00", "published_display": "12 Sep 2020 03:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RMN.F - MediciNova, Inc. Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBYMnpGSHNUNUF5ZlFIRUk0TktTRHNmaHA0dWpPV0o3OVNUS01ETUhxbjY4bk9FSUJFYXljdUtuZUhEZG4zS21iZA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-09-03T18:55:45+00:00", "published_display": "03 Sep 2020 18:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 74, "total_relevant": 38, "sentiment_summary": {"positive": 5, "negative": 2, "neutral": 31, "score": 51, "total": 38, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 15.4, "count": 28}, {"event": "earnings", "label": "Earnings", "weight": 4.2, "count": 9}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1.39, "latest_week": "2026-07-10", "one_week_move": -2.8, "four_week_move": 13.0, "twelve_week_move": -4.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.437721, "market_dynamics_buy_signal": false, "relative_strength": -15.541073, "fair_value_gap": -12.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.5848, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.8% over one week, +13.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GlobeNewswire", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "Market source", "count": 6}, {"label": "dars.gov.et", "count": 6}, {"label": "Ad Hoc News", "count": 2}, {"label": "Donan\u0131mHaber", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 30}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Earnings", "count": 9}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "30", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.8% over one week, +13.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN\u2011166 (ibudilast) in ALS patients"}], "updated_at": "2026-07-16T14:29:37.478890+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}